5 results about "Ebastine" patented technology

Methods of using a pharmaceutical composition comprising ebastine and alprazolam for treating patients suffering from one or more psychiatric disorders, such as major depressive disorder, generalized anxiety disorder, mild chronic depression, premenstrual dysphoric disorder are disclosed.

1. The name of the design product: medicine packaging box (ibudilast oral solution). 2. The use of the design product: the design is used for the outer packaging of ibudilast oral solution. 3. The design points of the design product: the combination of shape, pattern and color. 4. The picture or photo that best indicates the design points: perspective view. 5. The design claimed contains color.

The invention discloses a continuous intelligent tabletting all-in-one machine for ebastine medicine, which comprises a cabinet, an operation table is arranged on the cabinet through a stand column, the operation table is provided with a machine shell, a rotatable disc table is correspondingly arranged on the machine shell, a rotating motor for driving the disc table to rotate is arranged at the lower end of the machine shell, and the lower end of the machine shell is provided with a rotating motor for driving the disc table to rotate. Stamping holes are evenly formed in the disc table at intervals, and the stamping holes are of a vertically-through through hole structure. The operation table serves as a bearing foundation of the whole equipment, a stable mounting platform is provided for core components such as the machine shell and the ejection assembly, the overall stability of the equipment during operation is guaranteed, when the rotating motor is started, the disc table is driven to rotate synchronously, the multiple punching holes are evenly formed in the disc table in the circumferential direction in a penetrating mode, and the punching efficiency is improved along with rotation of the disc table. The punching holes can be sequentially and circularly switched to a feeding station, a punching station, an ejection station and the like, continuity of the ebastine tablet pressing process is achieved, the production efficiency of the ebastine tablets is greatly improved, and the use requirement is met.

The application discloses an ebastine tablet, which comprises the following raw materials in parts by weight: 10 parts of ebastine, 30-36 parts of a disintegrating agent, 144-155 parts of a filling agent, 1-3 parts of a lubricant, 1-3 parts of an auxiliary solvent, 6-8 parts of a binder, wherein the disintegrating agent is a composite microsphere. The ebastine tablet can solve the technical problems of poor dissolution and low bioavailability.

The invention belongs to the technical field of medicines, and particularly relates to an ebastine orally disintegrating tablet and a preparation method thereof. According to the ebastine orally disintegrating tablet, the microcrystalline cellulose and the mannitol are used as filling agents at the same time, the average particle size of the microcrystalline cellulose and the mannitol is controlled, the problem that in the prior art, the ebastine orally disintegrating tablet is poor in dissolution performance is solved, and the ebastine orally disintegrating tablet has good disintegration performance. The ebastine orally disintegrating tablet disclosed by the invention is obtained by firstly granulating through a fluidized bed and then tabletting, the tabletting is smooth and not astringent in the pressing process and has better compressibility, the fluidized bed granulating process is simple and easy to operate and control, the equipment is easy to obtain, the production cost is lower, and the ebastine orally disintegrating tablet is suitable for large-scale production.